ProPhase Labs Inc (NASDAQ: PRPH) suffers from exceptional negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume.
Recent important negative changes in fundamentals have impacted ProPhase Labs Inc (NASDAQ: PRPH): significant quarterly sales deceleration occurred, and significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, PRPH is expected to be a modest Value Eraser.
ProPhase Labs has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. ProPhase Labs has a slightly negative Appreciation Score of 35 and a very low Power Rating of 11, triggering the Lowest Value Trend Rating.
Recent Price Action
ProPhase Labs Inc (NASDAQ: PRPH) stock closed at $4.47 on 2/29/24 after a large decline of -5.7%. Moreover, this decline was accompanied by exceptionally high trading volume at 441% of normal. The stock has declined -9.7% during the last week and has been extremely weak relative to the market over the last nine months.
Be the first to comment